Company profile
Trueinvivo Limited
TRUEinvivo The micro silica thermoluminescent radiation detector company!
Trueinvivo Limited is a UK company with status active founded in 2014 based in South East England.
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts With Accounts Type Total Exemption Full
Accounts AnalysedAA | Transaction MzQ1NjM0NzU3M2FkaXF6a2N4
Published 25 Feb 2025 14:56
Capital Allotment Shares
CapitalSH01 | Transaction MzQzNzAwOTA3OGFkaXF6a2N4
Published 24 Sep 2024 01:01
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNTM4NDExN2FkaXF6a2N4
Published 12 Sep 2024 09:21
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Pre-clinical testing of glass bead dosimeters and related dose comparison software to enable safer hypofractionation to sustainably and quickly clear the radiotherapy treatment backlog caused by COVID-19.
1 Oct 2020 to 30 Jun 2021
**The extensive backlog in cancer treatment caused by COVID-19 is well documented. One solution in radiotherapy is to reduce the number of treatment sessions (called fractions) that a patient needs by increasing the strength of the delivered doses in each one, a technique called hypofractionation. For instance, a typical prostate treatment of 30 or 35 fra...
Development of a 3D cavity dosimeter and image analysis software for in-body invivo dose measurement of organs at risk to make radiotherapy safer for patients and more efficient for clinicians
1 Jan 2019 to 31 Mar 2021
It is currently estimated that 1 in 2 people will have cancer and of these around 40% will receive radiotherapy treatment (cancerresearchuk.org). Radiotherapy involves using ionising radiation to treat tumours and has been a key element of cancer treatment for decades. However 10-25% of radiotherapy patients are damaged or failed by their treatment often ...
TrueInvivo solution to improve cancer servival rate
1 Jan 2017 to 31 Dec 2018
Current radiotherapy treatments for cancer use beams of radiation to kill the actual tumour cells and try to miss the healthy surrounding cells and organs. However, the beams are invisible and very often damage does occur. Many radiotherapy centres use a pattern of tiny beams to closely match the shape of the target tumour but it is hugely difficult to kn...
TrueInvivo 2
1 Aug 2015 to 31 Jan 2016
Awaiting Public Project Summary